Crossmark

Identification of the "Collagen-Macrophage" sub-category of patients with colorectal cancer as an extension of the CMS4 subtype with THBS2 as a therapeutic target

Crossref DOI link: https://doi.org/10.1186/s12876-025-03918-8

Published Online: 2025-05-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Shuwen

Jiang, Zhaoyan

Song, Wanxuan

Lu, Chuqiao

Lin, Yanbing

Xu, Shiyao

Xie, Kunxin

Wan, Li

Yuan, Xiaoqin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81972288)
License Information

Text and Data Mining valid from 2025-05-08

Version of Record valid from 2025-05-08
More Information

Article History

Received: 4 July 2024

Accepted: 21 April 2025

First Online: 8 May 2025

Declarations

:

: This project was conducted in accordance with the Declaration of Helsinki and was approved by the research ethics committees of Nanjing Drum Tower Hospital (approval ID: 2020–378-01) and Nanjing Medical University (approval ID: (2016)640). All of the patients signed the written informed consent form before enrolled in this study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below